The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Flow cytometric analysis of circulating microparticles in plasma
Open accessAbstract
Microparticles, which include exosomes, micro‐vesicles, apoptotic bodies and apoptotic microparticles, are small (0.05 ‐ 3 μm in diameter), membranous vesicles that can contain DNA, RNA, miRNA, intracellular proteins and express extracellular surface markers from the parental cells. They can be secreted from intracellular multivesicular bodies or released from the surface of blebbing membranes. Circulating microparticles are abundant in the plasma of normal individuals and can be derived from circulating blood cells such as platelets, red blood cells and leukocytes as well as from tissue sources, such as endothelial and placental tissues. Elevated levels of microparticles are associated with various diseases such as thrombosis (platelet microparticles), congestive heart failure (endothelial microparticles), breast cancer patients (leukocyte microparticles) and women with preeclampsia (syncytiotrophoblast microparticles). Although microparticles can be detected by microscopy, enzyme‐linked immunoassays and functional assays, flow cytometry is the preferred method because of the ability to quantitate (fluorescent bead‐ or flow rate‐based method) and because of polychromatic capabilities. However, standardization of pre‐analytical and analytical modus operandi for isolating, enumerating and fluorescent labeling of microparticles remains a challenge. The primary focus of this article is to review the preliminary steps required to optimally study circulating in vivo microparticles which include: 1) centrifugation speed used, 2) quantitation of microparticles before antibody labeling, 3) levels of fluorescence intensity of antibody‐labeled microparticles, 4) polychromatic flow cytometric analysis of microparticle sub‐populations and 5) use of polyclonal antibodies designed for Western blotting for flow cytometry. These studies determine a roadmap to develop microparticles as biomarkers for a variety of conditions. © 2010 International Society for Advancement of Cytometry
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Membrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2567 · Cited by 3,882
Borst, O., Walker, B., Münzer, P., Russo, A., Schmid, E., Faggio, C., Bigalke, B., Laufer, S., Gawaz, M., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350110 · Cited by 1,860
Ruggeri, Z. M. (2002) · Nature Medicine · doi:10.1038/nm1102-1227 · Cited by 1,589
Théry, C., Boussac, M., Véron, P., Ricciardi-Castagnoli, P., Raposo, G., Garin, J., & Amigorena, S. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7309 · Cited by 1,563
Exosomal-like vesicles are present in human blood plasma
Caby, M.-P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., & Bonnerot, C. (2005) · International Immunology · doi:10.1093/intimm/dxh267 · Cited by 1,343
Exosomes with Immune Modulatory Features Are Present in Human Breast Milk
Admyre, C., Johansson, S. M., Qazi, K. R., Filén, J.-J., Lahesmaa, R., Norman, M., Neve, E. P. A., Scheynius, A., & Gabrielsson, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1969 · Cited by 1,217
High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients
Logozzi, M., De Milito, A., Lugini, L., Borghi, M., Calabrò, L., Spada, M., Perdicchio, M., Marino, M. L., Federici, C., Iessi, E., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005219 · Cited by 960
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
Nilsson, J., Skog, J., Nordstrand, A., Baranov, V, Mincheva-Nilsson, L., Breakefield, X. O., & Widmark, A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605058 · Cited by 776
Shet, A. S., Aras, O., Gupta, K., Hass, M. J., Rausch, D. J., Saba, N., Koopmeiners, L., Key, N. S., & Hebbel, R. P. (2003) · Blood · doi:10.1182/blood-2003-03-0693 · Cited by 539
Cited by
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
New Technologies for Analysis of Extracellular Vesicles
Shao, H., Im, H., Castro, C. M., Breakefield, X., Weissleder, R., & Lee, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00534 · Cited by 1,675
Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis
Dragovic, R. A., Gardiner, C., Brooks, A. S., Tannetta, D. S., Ferguson, D. J. P., Hole, P., Carr, B., Redman, C. W. G., Harris, A. L., Dobson, P. J., et al. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.04.003 · Cited by 1,362
Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study
Zaborowski, M. P., Balaj, L., Breakefield, X. O., & Lai, C. P. (2015) · BioScience · doi:10.1093/biosci/biv084 · Cited by 1,268
MicroRNA: Function, Detection, and Bioanalysis
Dong, H., Lei, J., Ding, L., Wen, Y., Ju, H., & Zhang, X. (2013) · Chemical Reviews · doi:10.1021/cr300362f · Cited by 1,224
Gurunathan, S., Kang, M.-H., Jeyaraj, M., Qasim, M., & Kim, J.-H. (2019) · Cells · doi:10.3390/cells8040307 · Cited by 1,122
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules
Labib, M., Sargent, E. H., & Kelley, S. O. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00220 · Cited by 976
Xin, H., Li, Y., Liu, Z., Wang, X., Shang, X., Cui, Y., Zhang, Z. G., & Chopp, M. (2013) · Stem Cells · doi:10.1002/stem.1409 · Cited by 720
Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine
Contreras-Naranjo, J. C., Wu, H.-J., & Ugaz, V. M. (2017) · Lab on a Chip · doi:10.1039/c7lc00592j · Cited by 640
Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine
Hade, M. D., Suire, C. N., & Suo, Z. (2021) · Cells · doi:10.3390/cells10081959 · Cited by 607
Consensus guidelines for the use and interpretation of angiogenesis assays
Nowak-Sliwinska, P., Alitalo, K., Allen, E., Anisimov, A., Aplin, A. C., Auerbach, R., Augustin, H. G., Bates, D. O., van Beijnum, J. R., Bender, R. H. F., et al. (2018) · Angiogenesis · doi:10.1007/s10456-018-9613-x · Cited by 590
Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis
Gardiner, C., Ferreira, Y. J., Dragovic, R. A., Redman, C. W. G., & Sargent, I. L. (2013) · Journal of Extracellular Vesicles · doi:10.3402/jev.v2i0.19671 · Cited by 584
The Methods of Choice for Extracellular Vesicles (EVs) Characterization
Szatanek, R., Baj-Krzyworzeka, M., Zimoch, J., Lekka, M., Siedlar, M., & Baran, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061153 · Cited by 563
van der Vlist, E. J., Nolte-'t Hoen, E. N. M., Stoorvogel, W., Arkesteijn, G. J. A., & Wauben, M. H. M. (2012) · Nature Protocols · doi:10.1038/nprot.2012.065 · Cited by 532
The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine
Qi, P., & Du, X. (2013) · Modern Pathology · doi:10.1038/modpathol.2012.160 · Cited by 506
Methodological challenges in utilizing mi RNA s as circulating biomarkers
Moldovan, L., Batte, K. E., Trgovcich, J., Wisler, J., Marsh, C. B., & Piper, M. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12236 · Cited by 436
“There are numerous published methods and several excellent reviews for EVs isolation and characterization from plasma or serum [115–118].”
MethodGyörgy, B., Módos, K., Pállinger, É., Pálóczi, K., Pásztói, M., Misják, P., Deli, M. A., Sipos, Á., Szalai, A., Voszka, I., et al. (2011) · Blood · doi:10.1182/blood-2010-09-307595 · Cited by 409
Salomon, C., Torres, M. J., Kobayashi, M., Scholz-Romero, K., Sobrevia, L., Dobierzewska, A., Illanes, S. E., Mitchell, M. D., & Rice, G. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098667 · Cited by 401
Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer
Li, Q., Shao, Y., Zhang, X., Zheng, T., Miao, M., Qin, L., Wang, B., Ye, G., Xiao, B., & Guo, J. (2015) · Tumor Biology · doi:10.1007/s13277-014-2807-y · Cited by 392
Exosomes in Cancer Diagnostics
Soung, Y., Ford, S., Zhang, V., & Chung, J. (2017) · Cancers · doi:10.3390/cancers9010008 · Cited by 368
Ueki, S., Melo, R. C. N., Ghiran, I., Spencer, L. A., Dvorak, A. M., & Weller, P. F. (2013) · Blood · doi:10.1182/blood-2012-05-432088 · Cited by 330
Raimondo, F., Morosi, L., Chinello, C., Magni, F., & Pitto, M. (2011) · PROTEOMICS · doi:10.1002/pmic.201000422 · Cited by 326
Di Bella, M. A. (2022) · Biology · doi:10.3390/biology11060804 · Cited by 304
Rak, J. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1267043 · Cited by 301
Digital Detection of Exosomes by Interferometric Imaging
Daaboul, G. G., Gagni, P., Benussi, L., Bettotti, P., Ciani, M., Cretich, M., Freedman, D. S., Ghidoni, R., Ozkumur, A. Y., Piotto, C., et al. (2016) · Scientific Reports · doi:10.1038/srep37246 · Cited by 292
An, T., Qin, S., Xu, Y., Tang, Y., Huang, Y., Situ, B., Inal, J. M., & Zheng, L. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27522 · Cited by 282
CHANDLER, W. L., YEUNG, W., & TAIT, J. F. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04283.x · Cited by 273
Xin, H., Wang, F., Li, Y., Lu, Q.-E., Cheung, W. L., Zhang, Y., Zhang, Z. G., & Chopp, M. (2017) · Cell Transplantation · doi:10.3727/096368916x693031 · Cited by 267
Lane, R. E., Korbie, D., Anderson, W., Vaidyanathan, R., & Trau, M. (2015) · Scientific Reports · doi:10.1038/srep07639 · Cited by 262
Diagnostic and Prognostic Potential of Extracellular Vesicles in Peripheral Blood
Revenfeld, A. L. S., Bæk, R., Nielsen, M. H., Stensballe, A., Varming, K., & Jørgensen, M. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.05.008 · Cited by 258
Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles
Hoen, E. N. M. N.-'., van der Vlist, E. J., Aalberts, M., Mertens, H. C. H., Bosch, B. J., Bartelink, W., Mastrobattista, E., van Gaal, E. V. B., Stoorvogel, W., Arkesteijn, G. J. A., et al. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.09.006 · Cited by 254
Elevated concentration of microvesicles isolated from peripheral blood in breast cancer patients
Galindo-Hernandez, O., Villegas-Comonfort, S., Candanedo, F., González-Vázquez, M.-C., Chavez-Ocaña, S., Jimenez-Villanueva, X., Sierra-Martinez, M., & Salazar, E. P. (2013) · Archives of Medical Research · doi:10.1016/j.arcmed.2013.03.002 · Cited by 152
Microparticles as a source of extracellular DNA
Pisetsky, D. S., Gauley, J., & Ullal, A. J. (2011) · Immunologic Research · doi:10.1007/s12026-010-8184-8 · Cited by 80
“As shown by flow cytometry using antibodies to cell surface markers, microparticles can arise from a variety of cell types although those from hematopoietic cells, platelets in particular, are the most abundant [4].”
BackgroundCancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery Nanotools
Palazzolo, S., Memeo, L., Hadla, M., Duzagac, F., Steffan, A., Perin, T., Canzonieri, V., Tuccinardi, T., Caligiuri, I., & Rizzolio, F. (2020) · Cancers · doi:10.3390/cancers12113165 · Cited by 34
Metadata
- Authors
- Orozco, A. F., & Lewis, D. E.
- Venue
- Cytometry Part A
- Publisher
- Wiley
- Published
- 2010-03-16
- Volume
- 77A
- Issue
- 6
- Pages
- 502-514
- ISSN
- 1552-4922 (ISSN-L)
- 1552-4930
- OpenAlex
- W2011575213
- Cited by
- 333
- References
- 54
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.